NCT04665765 2025-09-03Polatuzumab Vedotin, Rituximab, Ifosfamide, Carboplatin, and Etoposide (PolaR-ICE) as Initial Salvage Therapy for the Treatment of Relapsed/Refractory Diffuse Large B-Cell LymphomaCity of Hope Medical CenterPhase 2 Active not recruiting41 enrolled 12 charts
NCT02628405 2024-07-01R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell LymphomaAcademic and Community Cancer Research UnitedPhase 1/2 Active not recruiting30 enrolled 15 charts